Vantage Market Research.png
Ambulatory Surgical Center (ASC) Market to Reach Over USD 7.53 Billion by 2028 - Vantage Market Research
February 07, 2022 03:35 ET | Vantage Market Research
WASHINGTON, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The Global Ambulatory Surgical Center Market size is expected to reach over USD 7.53 Billion by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of...
Physician Growth Partners Advises Digestive Disease Consultants in a Partnership With One GI
January 19, 2022 09:00 ET | Physician Growth Partners
CHICAGO, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Physician Growth Partners ("PGP") is proud to have advised Digestive Disease Consultants ("DDC" or "the Practice") in a transaction with One GI, a private...
ProgenityLogo.jpg
Progenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology
January 11, 2022 06:30 ET | Progenity, Inc.
SAN DIEGO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
ProgenityLogo.jpg
Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
January 03, 2022 06:30 ET | Progenity, Inc.
SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
ProgenityLogo.jpg
Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab
December 20, 2021 16:05 ET | Progenity, Inc.
SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
Featured Image for Rome Foundation
New Study Shows Patients With Irritable Bowel Syndrome and Functional Dyspepsia Experience High Levels of Bloating and Distension
December 09, 2021 09:00 ET | Rome Foundation
RALEIGH, N.C., Dec. 09, 2021 (GLOBE NEWSWIRE) -- The Rome Foundation Research Institute and Danone Nutricia Research have partnered on a study to look at the prevalence of bloating and distension in...
Sonic Incytes_Secondary_Colour.jpg
Sonic Incytes Medical Corp. Successfully Completes Series A Raise of US$7.3M to Accelerate Velacur™ Commercialization
December 07, 2021 10:00 ET | Sonic Incytes Medical Corp.
VANCOUVER, British Columbia, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Sonic Incytes Medical Corp., a health technology company focused on liver health, is pleased to announce the completion of its US$7.3M...
ProgenityLogo.jpg
Progenity Announces New Patent for Single-Molecule Detection Technology
December 02, 2021 06:30 ET | Progenity, Inc.
SAN DIEGO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today announced a...
Featured Image for Rome Foundation
Rome Foundation Releases Clinical Criteria to Better Meet Needs of Patients
November 29, 2021 09:00 ET | Rome Foundation
RALEIGH, N.C., Nov. 29, 2021 (GLOBE NEWSWIRE) -- The Rome Foundation has published a groundbreaking modification of the Rome IV diagnostic criteria of the Disorders of Gut Brain Interaction (DGBI -...
ProgenityLogo.jpg
Progenity Strengthens its Liquidity Position
November 23, 2021 06:30 ET | Progenity, Inc.
Company received more than $44 million in warrant exercises since August 2021. Current liquidity position provides runway to achieve critical research and development milestones through 2022. SAN...